New Blog Coming Soon! – deals are closing!

Just a reminder that we are looking to make changes to our blog, but want to update on deals that closed!

Healthcare is alive and well!  Here are few recent closing!

eGenesis, a biotechnology company focused on utilizing genome editing technology in medical procedures, raised a $38 million in Series A funding. Biomatics Capital and ARCH Venture Partners led the round, with participation from Khosla Ventures, Alta Partners, Alexandria Venture Investments, Heritage Provider Network, Berggruen Holdings North America, Uprising, and Fan Ventures.

Peloton Therapeutics, a Dallas drug discovery and development company, raised $22.2 million in additional Series D funding, closing the round at $74.6 million.

908 Devices, a Boston developer of analytical devices for chemical and biomolecule analysis, raised $20 million in funding. Investors include Tao Capital Partners, Cormorant Asset Management, Saudi Aramco Energy Ventures, ARCH Venture Partners, Razor’s Edge Ventures, Schlumberger, and Casdin Capital.

NeuraLace, a San Diego, Calif. developer of non-opioid pain reduction treatment, raised $2 million in funding from FusionX Ventures.

Happy Networking and Investing,

JD Morris

JD Morris

Author: JDM

Learn more about JDM Biography on LinkedIn:

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.